Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Contributing writer

Nicole Golbari,
Stony Brook University School of Medicine
Stonybrook, NY,

Contributing writer Nicole Golbari is a fourth year medical student at Stony Brook University School of Medicine in Stony Brook, New York. She earned her bachelor’s degree in neurobiology from Harvard University in Cambridge, Massachusetts. She is currently completing a one-year clinical research fellowship under the supervision of IPC Board member Dr. Alexa B. Kimball at the Beth Israel Deaconess Medical Center in Boston, Massachusetts.

Last Updated: Apr 15, 2018

Latest news

January 06, 2021
Recently, the Task Force (TF) of the National Psoriasis Foundation (NPF) released a revised version of its COVID-19 statement after an in-depth analysis of publicly available data with two currently approved anti-SARS-CoV-2 vaccines in the US, both mRNA-based.
December 02, 2020
While the news of a potential SARS-CoV-2 vaccine is to be welcomed, the impact of psoriasis therapy, particularly systemic therapy, on the effectiveness and safety of vaccines needs to be considered.
November 19, 2020
Get the latest updates about psoriasis on topics such as pathogenesis, markers and therapeutics from Dr. Mohamed El-Komy in this short IPC video.
November 03, 2020
Get the latest news on treating psoriasis in the Middle East with Dr. El Sayed.
  More News

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK